Role of UV irradiation in aetiopathogenesis of malignant melanoma;Rola promieniowania UV w etiopatogenezie czerniaka skóry

Wspolczesna Onkologia

Volumn 11, Issue 9, 2007, Pages 419-429

  Wolnicka Głubisz, Agnieszka ^a   Płonka, Przemysław M ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

HGF SF; Melanin; Melanoma; Transgenic mouse; Ultraviolet

Indexed keywords

MELANIN; SCATTER FACTOR;

AGE; CANCER GROWTH; CANCER RISK; CANCER SUSCEPTIBILITY; DISEASE COURSE; DNA DAMAGE; DNA DETERMINATION; HISTOPATHOLOGY; HUMAN; MELANOCYTE; MELANOMA; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR; SEASONAL AFFECTIVE DISORDER; SKIN CARCINOGENESIS; SKIN PROTECTION; SUN EXPOSURE; TRANSGENIC MOUSE; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; ULTRAVIOLET C RADIATION; ULTRAVIOLET RADIATION;

EID: 38149002820     PISSN: 14282526     EISSN: 14282526     Source Type: Journal    
DOI: None     Document Type: Review

References (115)

1. Lens MB, Dawes M. Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br J Dermatol 2004; 150: 179-85.
2. Kycler W, Teresiak M. Czerniak skóry: aktualne możliwości leczenia w Polsce na podstawie analizy leczonych pacjentów i przegladu literatury. Współcz Onkol 2006; 10: 437-48.
3. Whiteman DC, Whiteman CA, Green AC. Childhood sun exposure as a risk factor for melanoma: a systematic review of epidemiologic studies. Cancer Causes Control 2001; 12: 69-82.
4. Lee JA, Scotto J. Melanoma: linked temporal and latitude changes in the United States. Cancer Causes Control 1993; 4: 413-8.
5. Hallberg O, Johansson O. Malignant melanoma of the skin - not a sunshine story! Med Sci Monit 2004; 10: CR336-40.
6. Bastuji-Garin S, Diepgen TL. Cutaneous malignant melanoma, sun exposure, and sunscreen use: epidemiological evidence. Br J Dermatol 2002; 146 Suppl. 61: 24-30.
7. Khlat M, Vail A, Parkin M, Green A. Mortality from melanoma in migrants to Australia: variation by age at arrival and duration of stay. Am J Epidemiol 1992; 135:1103-13.
8. Iscovich J, Howe GR. Cancer incidence patterns (1972-91) among migrants from the Soviet Union to Israel. Cancer Causes Control 1998; 9: 29-36.
9. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. Sunburn prevalence among adults - United States, 1999, 2003, and 2004. 2007; 56: 524-8.
10. Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 1988; 124: 869-71.
11. Byrd-Miles K, Toombs EL, Peck GL. Skin cancer in individuals of African, Asian, Latin-American, and American-Indian descent: differences in incidence, clinical presentation, and survival compared to Caucasians. J Drugs Dermatol 2007; 6: 10-6.
12. Zarebska Z. Promieniowanie słoneczne - dobroczynne działanie i zagrożenia. Kosmos 2000; 49: 27-39.
13. Lurie SJ, Gawinski B, Pierce D, Rousseau SJ. Seasonal affective disorder. Am Fam Physician 2006; 74: 1521-4.
14. Murray G, Michalak EE, Levitt AJ, Levitan RD, Enns MW, Morehouse R, Lam RW. O sweet spot where art thou? Light treatment of seasonal affective disorder and the circadian time of sleep. J Affect Disord 2006; 90: 227-31.
15. Berneburg M, Plettenberg H, Medve-Konig K, Pfahlberg A, Gers-Barlag H, Gefeller O, Krutmann J. Induction of the photoaging-associated mitochondrial common deletion in vivo in normal human skin. J Invest Dermatol 2004; 122: 1277-83.
16. Krutmann J. Ultraviolet A radiation-induced biological effects in human skin: relevance for photoaging and photodermatosis. J Dermatol Sci 2000; 23 Suppl. 1: S22-6.
17. Trembaczowski E. Wpływ promieniowania niejonizujacego na organizm żywy i niektóre zastosowania metod optycznych w medycynie. W: Podstawy Biofizyki. Podrecznik dla studentów medycyny. Pilawski A (red.). PZWL, Warszawa 1981; 375-92.
18. Osmancevic A, Landin-Wilhelmsen K, Larkö O, Mellstöm D, Wennberg AM, Hulthén L, Krogstad AL. UVB therapy increases 25 (OH) vitamin D syntheses in postmenopausal women with psoriasis. Photodermatol Photoimmunol Photomed 2007; 23: 172-8.
19. Jabłńska S, Chorzelski T. Choroby skóry dla studentów medycyny i lekarzy. Wydawnictwo Lekarskie PZWL, Warszawa 1994; 342-59.
20. Pourzand C, Tyrrell RM. Apoptosis, the role of oxidative stress and the example of solar UV radiation. Photochem Photobiol 1999; 70: 380-90.
21. Brudnik U, Wojas-Pelc A, Branicki W. Genetyczne uwarunkowania czerniaka. Artykuł pogladowy. Post Dermatol Alergol 2006; 23: 21-5.
22. Lamperska K, Przybyła A, Kaczmarek A, Leporowska E, Mackiewicz A. Podłoże genetyczne czerniaka - badania własne i przeglad piśmiennictwa. Współcz Onkol 2006; 10: 297-302.
23. Garinis GA, Mitchell JR, Moorhouse MJ, et al. Transcriptome analysis reveals cyclobutane pyrimidine dimers as a major source of UV-induced DNA breaks. EMBO J 2005; 24: 3952-62.
24. Sharpless E, Chin L. The INK4a/ARF locus and melanoma. Oncogene 2003; 22: 3092-8.
25. Cachia AR, Indsto JO, McLaren KM, Mann GJ, Arends MJ. CDKN2A mutation and deletion status in thin and thick primary melanoma. Clin Cancer Res 2000; 6: 3511-5.
26. Fotedar R, Bendjennat M, Fotedar A. Functional analysis of CDK inhibitor p21WAF1. Methods Mol Biol 2004; 281: 55-71.
27. Medrano EE, Im S, Yang F, Abdel-Malek ZA. Ultraviolet B light induces G1 arrest in human melanocytes by prolonged inhibition of retinoblastoma protein phosphorylation associated with long-term expression of the p21Waf-1/SDI-1/Cip-1 protein. Cancer Res 1995; 55: 4047-52.
28. Yang Q, Manicone A, Coursen JD, Linke SP, Nagashima M, Forgues M, Wang XW. Identification of a functional domain in a GADD45-mediated G2/M checkpoint. J Biol Chem 2000; 275: 36892-98.
29. Jin S, Antinore MJ, Lung FD, et al. The GADD45 inhibition of Cdc2 kinase correlates with GADD45-mediated growth suppression. J Biol Chem 2000; 275: 16602-8.
30. Takahashi S, Saito S, Ohtani N, Sakai T. Involvement of the Oct-1 regulatory element of the gadd45 promoter in the p53-independent response to ultraviolet irradiation. Cancer Res 2001; 61: 1187-95.
31. Herzinger T, Funk JO, Hillmer K, Eick D, Wolf DA, Kind P. Ultraviolet B irradiation-induced G2 cell cycle arrest in human keratinocytes by inhibitory phosphorylation of the cdc2 cell cycle kinase. Oncogene 1995; 11: 2151-6.
32. Gabrielli BG, Clark JM, McCormack AK, Ellem KA. Hyperphosphorylation of the N-terminal domain of Cdc25 regulates activity toward cyclin B1/Cdc2 but not cyclin A/Cdk2. J Biol Chem 1997; 272: 28607-14.
33. Pavey S, Russell T, Gabrielli B. G2 phase cell cycle arrest in human skin following UV irradiation. Oncogene 2001; 20: 6103-10.
34. Bulavin DV, Higashimoto Y, Popoff IJ, Gaarde WA, Basrur V, Potapova O, Appella E, Fornace AJ Jr. Initiation of a G2/M checkpoint after ultraviolet radiation requires p38 kinase. Nature 2001; 411: 102-7.
35. Shaulian E, Schreiber M, Piu F, Beeche M, Wagner EF, Karin M. The mammalian UV response: c-Jun induction is required for exit from p53-imposed growth arrest. Cell 2000; 103: 897-907.
36. Brose MS, Volpe P, Feldman M, et al. BRAF and RAS mutations in human lung cancer and melanoma. Cancer Res 2002; 62: 6997-7000.
37. Davies H, Bignell GR, Cox C, et al. Mutations of the BRAF gene in human cancer. Nature 2002; 417: 949-54.
38. Maldonado JL, Fridlyand J, Patel H, et al. Determinants of BRAF mutations in primary melanomas. J Natl Cancer Inst 2003; 95: 1878-90.
39. Bauer J, Curtin JA, Pinkel D, Bastian BC. Congenital melanocytic nevi frequently harbor NRAS mutations but no BRAF mutations. J Invest Dermatol 2007; 127: 179-82.
40. Bonitsis N, Batistatou A, Karantima S, Charalabopoulos K. The role of cadherin/catenin complex in malignant melanoma. Exp Oncol 2006; 28: 187-93.
41. Jamal S, Schneider RJ. UV-induction of keratinocyte endothelin-1 downregulates E-cadherin in melanocytes and melanoma cells. J Clin Invest 2002; 110: 443-52.
42. Clydesdale GJ, Dandie GW, Muller HK. Ultraviolet light induced injury: immunological and inflammatory effects. Immunol Cell Biol 2001; 79: 547-68.
43. Genetyka molekularna. Wegleński P (red.). Wyd. Naukowe PWN, Warszawa 1996.
44. de Gruijl FR. Photobiology of photocarcinogenesis. Photochem Photobiol 1996; 63: 372-5.
45. Cleaver JE, Crowley E. UV damage, DNA repair and skin carcinogenesis. Front Biosci 2002; 7: 1024-43.
46. D'Errico M, Teson M, Calcagnile A, et al. Differential role of transcription-coupled repair in UVB-induced response of human fibroblasts and keratinocytes. Cancer Res 2005; 65: 432-8.
47. Islas AL, Hanawalt PC. DNA repair in the MYC and FMS proto-oncogenes in ultraviolet light-irradiated human HL60 promyelocytic cells during differentiation. Cancer Res 1995; 55: 336-41.
48. Tornaletti S, Rozek D, Pfeifer GP. Mapping of UV photoproducts along the human P53 gene. Ann N Y Acad Sci 1994; 726: 324-6.
49. Hoeijmakers JH. From xeroderma pigmentosum to the biological clock contributions of Dirk Bootsma to human genetics. Mutat Res 2001; 485: 43-59.
50. Kraemer KH. Nucleotide excision repair genes involved in xeroderma pigmentosum. Jpn J Cancer Res 1994; 85: inside front cover.
51. Itoh T, Yamaizumi M, Ichihashi M, Hiro-Oka M, Matsui T, Matsuno M, Ono T. Clinical characteristics of three patients with UVs syndrome, a photosensitive disorder with defective DNA repair. Br J Dermatol 1996; 134: 1147-50.
52. van der Horst GT, van Steeg H, Berg RJ, et al. Defective transcription-coupled repair in Cockayne syndrome B mice is associated with skin cancer predisposition. Cell 1997; 89: 425-35.
53. Boonstra A, van Oudenaren A, Baert M, et al. Differential ultraviotet-B-induced immunomodulation in XPA, XPC, and CSB DNA repair-deficient mice. J Invest Dermatol 2001; 117: 141-6.
54. Choroby wewnetrzne. Przyczyny, rozpoznanie i leczenie. Szczeklik A (red.). tom I. Medycyna Praktyczna, Kraków 2005.
55. Anderson DJ. The neural crest cell lineage problem: neuropoiesis? Neuron 1989; 3:1-12.
56. Bomirski A, Slominski A, Bigda J. The natural history of a family of transplantable melanomas in hamsters. Cancer Met Rev 1988; 7: 95-119.
57. Slominski A, Paus R. Bomirski melanomas: a versatile and powerful model for pigment cell and melanoma research. Int J Oncol 1993; 2: 221-8.
58. Plonka PM, Slominski AT, Pajak S, Urbanska K. Transplantable melanomas in gerbils (Meriones unguiculatus). II - melanogenesis. Exp Dermatol 2003; 12: 356-64.
59. Van Den Bossche K, Naeyaert JM, Lambert J. The quest for the mechanism of melanin transfer. Traffic 2006; 7: 769-78.
60. Slominski A, Tobin DJ, Shibahara S, Wortsman J. Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev 2004; 84: 1155-228.
61. Sawicki W. Histologia. Podrecznik dla studentów. Wydawnictwo Lekarskie PZWL, Warszawa 1993.
62. Borovanský J, Elleder M. Melanosome degradation: fact or fiction. Pigment Cell Res 2003; 16: 280-6.
63. Wood JM, Jimbow K, Boissy RE, Slominski A, Plonka PM, Slawinski J, Wortsman J, Tosk J. What is the use of generating melanin. Exp Dermatol 1999; 8: 153-64.
64. Plonka PM, Grabacka M. Melanin synthesis in microorganisms - biotechnological and medical aspects. Acta Biochim Pol 2006; 53: 429-43.
65. Jablonski NG, Chaplin G. The evolution of human skin coloration. J Hum Evol 2000; 39: 57-106.
66. Branda RF, Eaton JW. Skin color and nutrient photolysis: an evolutionary hypothesis. Science 1978; 201: 625-6.
67. Hill HZ, Hill GJ, Cieszka K, Plonka PM, Mitchell DL, Meyenhofer MF, Xin P, Boissy RE. Comparative action spectrum for ultraviolet light killing of mouse melanocytes from different genetic coat color backgrounds. Photochem Photobiol 1997; 65: 983-9.
68. Agar N, Young AR. Melanogenesis: a photoprotective response to DNA damage? Mutat Res 2005; 571: 121-32.
69. Roméro-Graillet C, Aberdam E, Aberdam E, Biagoli N, Ortonne JP, Ballotti R. Ultraviolet B radiation acts through the nitric oxide and cGMP signal transduction pathway to stimulate melanogenesis in human melanocytes. J Biol Chem 1996; 271: 28052-6.
70. Roméro-Grailtet C, Aberdam E, Clément M, Ortonne JP, Ballotti R. Nitric oxide produced by ultraviolet-irradiated keratinocytes stimulates melanogenesis. J Clin Invest 1997; 99: 635-42.
71. Atoyan RY, Sharov AA, Eller MS, Sargsyan A, Botchkarev VA, Gilchrest BA. Oligonucleotide treatment increases eumelanogenesis, hair pigmentation and melanocortin-1 receptor expression in the hair follicle. Exp Dermatol 2007; 16: 671-7.
72. Hasse S, Chernyavsky AI, Grando SA, Paus R. The M4 muscarinic acetylcholine receptor plays a key role in the control of murine hair follicle cycling and pigmentation. Life Sci 2007; 80: 2248-52.
73. Pawelek JM, Chakraborty AK. The enzymology of melanogenesis. In: The Pigmentary System. Physiology and Patophysiology. Nordlund JJ, Boissy RE, Hearing VJ, King RA, Ortonne JP (eds). 1st edition. Oxford University Press, Oxford - New York 1998; 391-400.
74. Ortonne JP, Ballotti R. Melanocyte biology and melanogenesis: what's new? J Dermatol Treat 2000; 11: S15-26.
75. Oyehaug L, Plathe E, Vage D I, Omholt SW. The regulatory basis of melanogenic switching. J Theor Biol 2002; 215: 449-68.
76. Riley PA. Melanogenesis: a realistic target for antimelanoma therapy? Eur J Cancer 1991; 27: 1172-7.
77. Sarna T, Plonka PM. Biophysical Studies of Melanin: Paramagnetic, Ion-Exchange and Redox Properties of Melanin Pigments and Their Photoreactivity. In: Biomedical ESR. vol. 23 of the Biological Magnetic Resonance Series. Eaton SS, Eaton GR, Berliner LJ (eds). Kluwer Academic Publishers, The Netherlands - New York - Boston 2005; 125-46.
78. Schmitz S, Thomas PD, Allen TM, Poznansky MJ, Jimbow K. Dual role of melanins and melanin precursors as photoprotective and phototoxic agents: inhibition of ultraviolet radiationinduced lipid peroxidation. Photochem Photobiol 1995; 61: 650-5.
79. Nowak-Sliwinska P, Karocki A, Elas M, Pawlak A, Stochel G, Urbanska K. Verteporfin, photofrin II, and merocyanine 540 as PDT photosensitizers against melanoma cells. Biochem Biophys Res Commun 2006; 349: 549-55.
80. Stevens G, Hong A. Radiation therapy in the management of cutaneous melanoma. Surg Oncol Clin N Am 2006; 15: 353-71.
81. Urbanska K, Romanowska-Dixon B, Elas M, Pajak S, Paziewski E, Bryk J, Kukielczak B, Slominski A, Zygulska-Mach H, Lukiewicz S. Experimental ruthenium plaque therapy of amelanotic and metanotic melanomas in the hamster eye. Melanoma Res 2000; 10: 26-35.
82. Kozik A, Korytowski W, Sarna T, Bloom AS. Interactions of flavins with melanin. Studies on equilibrium binding of riboflavin to dopamelanin and some spectroscopic characteristics of flavinmelanin complex. Biophys Chem 1990; 38: 39-48.
83. Larsson B, Tjalve H. Studies on the mechanism of drug binding to melanin. Biochem Pharmacol 1979; 28: 1181-7.
84. Halaban R, Lerner AB. Tyrosinase and inhibition of proliferation of melanoma cells and fibroblasts. Exp Cell Res 1977; 108: 119-25.
85. Pawelek JM, Lerner AB. 5,6-dihydroxyindole is a melanin precursor showing potent cytotoxicity. Nature 1978; 276: 626-8.
86. Hill HZ, Hill GJ. Eumelanin causes DNA strand breaks and kills cells. Pigment Cell Res 1987; 1: 163-70.
87. Korytowski W, Pilas B, Sarna T, Kalyanaraman B. Photoinduced generation of hydrogen peroxide and hydroxyl radicals in melanin. Photochem Photobiol 1987; 45: 185-90.
88. Slominski A, Paus R, Mihm MC. Inhibition of melanogenesis as an adjuvant strategy in the treatment of melanotic melanomas: selective review and hypothesis. Anticancer Res 1998; 18, 3709-16.
89. Miller SJ, Wei ZG, Wilson C, Dzubow L, Sun TT, Lavker RM. Mouse skin is particularly susceptible to tumor initiation during early anagen of the hair cycle: possible involvement of hair follicle stem cells. J Invest Dermatol 1993; 101: 591-4.
90. Weinstein GD, Mooney KM. Cell proliferation kinetics in the human hair root. J Invest Dermatol 1980; 74: 43-6.
91. Slominski A, Paus R. Melanogenesis is coupled to murine anagen: toward new concepts for the role of melanocytes and the regulation of melanogenesis in hair growth. J Invest Dermatol 1993; 101: 90S-97S.
92. Slominski A, Wortsman J, Carlson A J, Matsuoka LY, Balch CM, Mihm M. Malignant melanoma. Arch Pathol Lab Med 2001; 125: 1295-306.
93. Slominski A, Wortsman J, Nickoloff B, McClatchey K, Mihm MC, Ross JS. Molecular pathology of malignant melanoma. Am J Clin Pathol 1998; 110: 788-94.
94. Cascinelli N, Herlyn M, Schneeberg A, et al. What is the most promising strategy for the treatment of metastasizing melanoma? Exp Dermatol 2000; 9: 439-51.
95. Bertolotto C, Abbe P, Hemesath TJ, Bille K, Fisher DE, Ortonne JP, Balotti R. Microphthalmia gene product as a signal transducer in cAMP-induced differentiation of melanocytes. J Cell Biol 1998; 142: 827-35.
96. Englaro W, Bertolotto C, Busca R, Brunet A, Pages G, Ortonne JP, Ballotti R. Inhibition of the mitogen-activated protein kinase pathway triggers B16 melanoma cell differentiation. J Biol Chem 1998; 273: 9966-70.
97. Haddad MM, Xu W Schwahn DJ, Liao F, Medrano EE. Activation of a cAMP pathway and induction of melanogenesis correlate with association of p16 (INK4) and p27 (KIP1) to CDKs, loss of E2F-binding activity, and premature senescence of human melanocytes. Exp Cell Res 1999; 253: 561-72.
98. Bennett DC, Medrano EE. Molecular regulation of melanocyte senescence. Pigment Cell Res 2002; 15: 242-50.
99. Nishimura I, Shimizu S, Sakoda JY, Yoshikawa K. Expression of Drosophila MAGE gene encoding a necclin homologous protein in postembryonic neurogenesis. Gene Expr Patterns 2007; 7: 244-51.
100. Meierjohann S, Schartl M. From Mendelian to molecular genetics: the Xiphophorus melanoma model. Trends Genet 2006; 22: 654-61.
101. Wood SR, Berwick M, Ley RD, Walter RB, Setlow RB, Timmins GS. UV causation of melanoma in Xiphophorus is dominated by melanin photosensitized oxidant production. Proc Natl Acad Sci U S A 2006; 103: 4111-5.
102. Parsons PG, Takahashi H, Candy J, Meyers B, Vickers J, Kelly WR, Smith I, Spradbrow P. Histopathology of melanocytic lesions in goats and establishment of a melanoma cell line: a potential model for human melanoma. Pigment Cell Res 1990; 3: 297-305.
103. Smith SH, Goldschmidt MH, McManus PM. A comparative review of melanocytic neoplasms. Vet Pathol 2002; 39: 651-78.
104. Pajak S, Cieszka K, Plonka P, Lukiewicz S, Mihm M, Slominski A. Transplantable melanomas in gerbils (Meriones unguiculatus). I. Origin, morphology and growth rate. Anticancer Res 1996; 16: 1203-8.
105. Green EL. Handbook of Genetically Standardized JAX Mice. Bar Harbor Times Publishing Company, Bar Harbor, Maine 1962.
106. Loustalot P, Algire GH, Legallais FY, Anderson BF. Growth and histopathology of melanotic and amelanotic derivatives of the Cloudman melanoma S91. J Natl Cancer Inst 1952; 12: 1079-117.
107. Noonan FP, Dudek J, Merlino G, De Fabo EC. Animal models of melanoma: an HGF/SF transgenic mouse model may facilitate experimental access to UV initiating events. Pigment Cell Res 2003; 16: 16-25.
108. Slominski A, Wortsman J, Plonka PM, Schallreuter KU, Paus R, Tobin DJ. Hair follicle pigmentation. J Invest Dermatol 2005; 124: 13-21.
109. Noonan FP, Recio JA, Takayama H, Duray P, Anvers MR, Rush WL, de Fabo EC, Merlino G. Neonatal sunburn and melanoma in mice. Nature 2001; 413: 271-2.
110. Komada M, Kitamura N. The cell dissociation and motility triggered by scatter factor/hepatocyte growth factor are mediated through the cytoplasmic domain of the c-Met receptor. Oncogene 1993; 8: 2381-90.
111. Otsuka T, Takayama H, Sharp R, et al. c-Met autocrine activation induces development of malignant melanoma and acquisition of the metastatic phenotype. Cancer Res 1998; 58: 5157-67.
112. Recio JA, Noonan FP, Takayama H, et al. Ink4a/arf deficiency promotes ultraviolet radiation-induced melanomagenesis. Cancer Res 2002; 62: 6724-30.
113. De Fabo EC, Noonan FP, Fears T, Merlino G. Ultraviolet B but not ultraviolet A radiation initiates melanoma. Cancer Res 2004; 64: 6372-6.
114. Yamazaki F, Okamoto H, Miyauchi-Hashimoto H, Matsumura Y, Itoh T, Tanaka K, Kunisada T, Horio T. XPA gene-deficient, SCF-transgenic mice with epidermal melanin are resistant to UV-induced carcinogenesis. J Invest Dermatol 2004; 123: 220-8.
115. Alexeev V, Yoon K. Distinctive role of the ckit receptor tyrosine kinase signaling in mammalian melanocytes. J Invest Dermatol 2006; 126: 1102-10.